Incyte Corp. (INCY)
98.95
-2.10
(-2.08%)
USD |
NASDAQ |
Feb 25, 12:10
Incyte Research and Development Expense (Quarterly) : 595.19M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Centene Corp. | -- |
| CVS Health Corp. | -- |
| Molina Healthcare, Inc. | -- |
| Xencor, Inc. | 54.37M |